Kasahara N
Department of Endocrinology, Tokyo Medical and Dental University.
Bull Tokyo Med Dent Univ. 1993 Jun;40(2):79-91.
Identification of regulatory elements in the human renin gene promoter has been hindered by the lack of suitable renin-expressing cell lines. In this paper, the SV40 viral enhancer is coupled to a human renin promoter/chloramphenicol acetyltransferase (CAT) reporter gene construct, to determine whether promoter regulatory elements can be identified in the context of enhanced transcription in the normally non-renin-expressing HeLa cell line. The present results indicate that the SV40 enhancer can overcome tissue-specificity of the human renin promoter, and confer correctly initiated transcriptional activity to HeLa cells. Analysis of a series of 5'-end deletions of the human renin promoter linked to the CAT gene and SV40 enhancer identified negative regulatory elements between positions-275 and -225, and between-142 and -102 of the human renin promoter, as well as a positive regulatory element between -225 and -142. Thus, studies of renin promoter regulatory elements need not be limited to renin-expressing cells, but can be performed in non-renin-expressing cells with the addition of an enhancer. This strategy can be generally applicable to the study of tissue-specific gene regulation in cases where there are no specific cell lines available.
由于缺乏合适的表达肾素的细胞系,人类肾素基因启动子中调控元件的鉴定工作受到了阻碍。在本文中,将SV40病毒增强子与人类肾素启动子/氯霉素乙酰转移酶(CAT)报告基因构建体相结合,以确定在通常不表达肾素的HeLa细胞系中增强转录的情况下,是否能够鉴定启动子调控元件。目前的结果表明,SV40增强子能够克服人类肾素启动子的组织特异性,并赋予HeLa细胞正确起始的转录活性。对一系列与CAT基因和SV40增强子相连的人类肾素启动子5'端缺失进行分析,确定了人类肾素启动子中-275至-225位以及-142至-102位之间的负调控元件,以及-225至-142位之间的正调控元件。因此,肾素启动子调控元件的研究不必局限于表达肾素的细胞,而是可以在添加增强子的非表达肾素的细胞中进行。在没有可用特定细胞系的情况下,该策略通常可应用于组织特异性基因调控的研究。